Genetically engineered oncolytic Newcastle disease virus effectively induces sustained remission of malignant pleural mesothelioma
/in International Publications, Malignant Pleural Mesothelioma, Newcastle Disease Virus /von 2010-09-21 / Mol. Cancer Ther. 2010 Oct;9(10):2761-9Measurement and mathematical modeling of thermally induced injury and heat shock protein expression kinetics in normal and cancerous prostate cells
/in Hyperthermia, International Publications, Prostate Cancer /von 2010-09-21 / Int J Hyperthermia 2010;26(8):748-64Intracavity hyperthermia in nasopharyngeal cancer: a phase III clinical study
/in Hyperthermia, International Publications /von 2010-09-21 / Int J Hyperthermia 2011;27(2):180-6IFN{gamma} markedly cooperates with intratumoral dendritic cell vaccine in dog tumor models
/in Dendritic Cells, International Publications /von 2010-09-07 / Cancer Res. 2010 Sep;70(18):7093-101Dendritic cell vaccination of patients with metastatic colorectal cancer
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2010-09-01 / Dan Med Bull 2010 Sep;57(9):B4171Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2010-09-01 / PLoS ONE 2010 Sep;5(9)Immunological response after therapeutic vaccination with WT1 mRNA-loaded dendritic cells in end-stage endometrial carcinoma
/in Dendritic Cells, Endometrial Cancer, International Publications /von 2010-09-01 / Anticancer Res 2010 Sep;30(9):3709-14Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2010-08-24 / Clin. Cancer Res. 2010 Oct;16(20):5067-78Dendritic cells-mediated CTLs targeting hepatocellular carcinoma stem cells
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2010-08-22 / Cancer Biol. Ther. 2010 Aug;10(4):368-75IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de